Angiotensin AT1 and AT2 receptor antagonists modulate nicotine-evoked [3H]dopamine and [3H]norepinephrine release

Vidya Narayanaswami, Sucharita S. Somkuwar, David B. Horton, Lisa A. Cassis, Linda P. Dwoskin

Research output: Contribution to journalArticlepeer-review

14 Scopus citations

Fingerprint

Dive into the research topics of 'Angiotensin AT1 and AT2 receptor antagonists modulate nicotine-evoked [3H]dopamine and [3H]norepinephrine release'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science